ResMed
765 hedge funds and large institutions have $16.3B invested in ResMed in 2024 Q2 according to their latest regulatory filings, with 117 funds opening new positions, 305 increasing their positions, 238 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
765
Holders Change
+54
Holders Change %
+7.59%
% of All Funds
11.13%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
117
Increased
305
Reduced
238
Closed
54
Calls
$180M
Puts
$272M
Net Calls
-$91.9M
Net Calls Change
+$79.8M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
$1.11B |
| 2 |
Morgan Stanley
New York
|
$650M |
| 3 |
Marshall Wace
London,
United Kingdom
|
$77.3M |
| 4 |
Millennium Management
New York
|
$83.5M |
| 5 |
GC
Greenvale Capital
London,
United Kingdom
|
$139M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
$82.7M |
| 2 |
JPMorgan Chase & Co
New York
|
$104M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$195M |
| 4 |
ATO
Alecta Tjanstepension Omsesidigt
Stockholm,
Sweden
|
$0 |
| 5 |
BlackRock
New York
|
$2.24B |
